The report Regurgitation Global Clinical Trials Review, H1, 2018 gives an overview of the global clinical trials landscape and top-level data related to clinical trials by Regio, Country (G7 and E7), Trial Status, trial Phase, Sponsor type, and Endpoint status. The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company and all the unaccomplished trials (Terminated, Suspended and Withdrawn) with the reason for their non-accomplishments. It provides enrolment trends for the past five years and the latest news relating to these trials for the past three months. The companies involved in the clinical trials of Regurgitation are AstraZeneca Plc, Novartis AG, Healthypharm BV, SOFAR SpA, Pierre Fabre Foundation, Pacira Pharmaceuticals Inc. Johnson & Johnson, GlaxoSmithKline Plc, C. H. Boehringer Sohn AG & Co KG and BioGaia AB. The report will enhance the decision- making capabilities and helps to create an effective counter-strategy to gain a competitive advantage. Regurgitation is a disorder where food or liquid moves back up from the stomach and exits through the mouth. It requires very minimal effort and nausea. The real cause of regurgitation is unknown but frequent regurgitation may lead to severe health disorders. However, digestive issues, oesophageal sphincter, Parkinson’s disease, sclerosis show the symptoms of regurgitation. The symptoms include abdominal pain, effortless vomiting, bloating, constipation, dental erosion. Regurgitation may lead to serious other problems if left unattended and can be prevented with a few changes towards a healthier lifestyle. Clinical trials are conducted in medical research labs to find better ways to prevent and treat diseases or diagnose them. They give solutions to the medical approaches suitable for certain illness to a certain group of people specifically. These trials help a great deal in making healthcare decisions. Since they answer scientific questions, these trials are required to be carried on under strict and scientific standards that protect the interests of the patients. They are also the final and the most important stage of clinical research and development. Clinical trials for drugs take place in four phases- first. They test an experimental drug on a few people and study the effects; second, they test the drug on more people than in Phase 1 which may extend up to years; third, they include many other participants to test for safety and efficacy and study the side effects deeper than in Phase 2; fourth, getting approval of the usage of drug from the relevant authority.
